Wæhre Torgun, Tunheim Gro, Bodin Johanna Eva, Laake Ida, Kvale Dag, Kran Anne-Marte Bakken, Brekke Hanne, Løken Ragnhild, Oftung Fredrik, Mjaaland Siri, Dyrhol-Riise Anne Margarita
Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway.
Infect Dis (Lond). 2022 May;54(5):367-377. doi: 10.1080/23744235.2021.2022196. Epub 2022 Jan 4.
Seasonal influenza causes substantial numbers of hospitalizations annually. We have characterized the clinical picture and treatment practice in hospitalized adult influenza patients and assessed whether clinical risk scores on admission or influenza type were associated with severe outcomes.
Clinical characteristics and risk scores on admission (CRB65, CRB, SIRS and uick equential rgan ailure ssessment [qSOFA]), treatment and severe outcomes (defined as: stay in intensive care unit (ICU), receiving oxygen supplementation or staying ≥5 days in hospital), were recorded in patients hospitalized with influenza at Oslo University Hospital, Norway, between 2014 and 2018.
Among the 156 included patients, 52.6% had influenza A(H3N2), 32.6% influenza B and 12.8% influenza A(H1N1). Median age was 70 years and 59.6% of patients were ≥65 years. Nine (5.8%) of the patients were treated in ICU, 43.0% received oxygen and 47.4% stayed ≥5 days in hospital. Overall, 34.6% of the patients had a high CRB score on admission which was associated with stay in ICU and oxygen supplementation. Multivariate analyses identified age, and pneumonia (46.8%), but not influenza type, to be associated with severe outcomes. Antiviral treatment was given to 37.2% of the patients, while 77.6% received antibiotics. Only 25.5% of patients with influenza B received antiviral therapy.
The influenza patients were mostly elderly, and few patients were treated in ICU. A high CRB score was associated with severe outcomes with possible implications for patient monitoring. Less than 40% of the patients received antiviral therapy, whereas the majority were treated with antibiotics, indicating potential for optimising treatment strategies.
季节性流感每年导致大量住院病例。我们已对住院成年流感患者的临床表现和治疗方法进行了描述,并评估了入院时的临床风险评分或流感类型是否与严重后果相关。
记录了2014年至2018年期间在挪威奥斯陆大学医院住院的流感患者的临床特征和入院时的风险评分(CRB65、CRB、全身炎症反应综合征和快速序贯器官衰竭评估[qSOFA])、治疗情况及严重后果(定义为:入住重症监护病房[ICU]、接受氧疗或住院≥5天)。
在纳入的156例患者中,52.6%为甲型(H3N2)流感,32.6%为乙型流感,12.8%为甲型(H1N1)流感。中位年龄为70岁,59.6%的患者年龄≥65岁。9例(5.8%)患者在ICU接受治疗,43.0%接受了氧疗,47.4%住院≥5天。总体而言,34.6%的患者入院时CRB评分较高,这与入住ICU和接受氧疗相关。多因素分析确定年龄以及肺炎(46.8%)与严重后果相关,而流感类型与严重后果无关。37.2%的患者接受了抗病毒治疗,77.6%的患者接受了抗生素治疗。仅25.5%的乙型流感患者接受了抗病毒治疗。
流感患者大多为老年人,在ICU接受治疗的患者较少。CRB评分高与严重后果相关,这可能对患者监测具有启示意义。不到40%的患者接受了抗病毒治疗,而大多数患者接受了抗生素治疗,这表明优化治疗策略具有潜力。